Stay updated on RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial page.

Latest updates to the RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded Revision: v3.4.2 and removed Revision: v3.4.1 from the page history.SummaryDifference0.1%

- Check19 days agoChange DetectedA new revision entry v3.4.1 was added and v3.4.0 removed in the record history, indicating a metadata update to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedA new revision entry v3.3.4 was added (replacing v3.3.3) in the page history, a metadata update that does not modify study data or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedAdded Revision: v3.3.3 to the record history and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer.SummaryDifference0.2%

- Check91 days agoChange DetectedNew revision entry v3.3.2 has been added to the record history, and revision v3.2.0 has been removed.SummaryDifference0.1%

- Check99 days agoChange DetectedRemoved the site-wide government funding operating-status notice from the page; this notice did not pertain to the trial details or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RMC-6291 Monotherapy in KRASG12C Mutant Solid Tumors Clinical Trial page.